207 related articles for article (PubMed ID: 28534645)
1. The mitochondria-targeting peptide elamipretide diminishes circulating HtrA2 in ST-segment elevation myocardial infarction.
Hortmann M; Robinson S; Mohr M; Mauler M; Stallmann D; Reinöhl J; Duerschmied D; Peter K; Carr J; Gibson CM; Bode C; Ahrens I
Eur Heart J Acute Cardiovasc Care; 2019 Dec; 8(8):695-702. PubMed ID: 28534645
[TBL] [Abstract][Full Text] [Related]
2. Circulating HtrA2 as a novel biomarker for mitochondrial induced cardiomyocyte apoptosis and ischemia-reperfusion injury in ST-segment elevation myocardial infarction.
Hortmann M; Robinson S; Mohr M; Haenel D; Mauler M; Stallmann D; Reinoehl J; Duerschmied D; Peter K; Bode C; Ahrens I
Int J Cardiol; 2017 Sep; 243():485-491. PubMed ID: 28602551
[TBL] [Abstract][Full Text] [Related]
3. Circulating HtrA2 after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: A potential novel biomarker for mitochondrial induced cardiomyocyte apoptosis and ischemia-reperfusion injury.
Hortmann M; Robinson S; Mohr M; Haenel D; Mauler M; Laumann R; Stallmann D; Reinoehl J; Duerschmied D; Peter K; Bode C; Ahrens I
Int J Cardiol; 2017 Dec; 249():437. PubMed ID: 29121749
[No Abstract] [Full Text] [Related]
4. Apoptosis kinetics at reperfusion period in patients with acute ST-Segment Elevation Myocardial Infarction undergoing primary percutaneous coronary intervention and treated with thrombolytic therapy.
Gultekin N; Bulut G; Kucukates E; Yildiz A; Kocas C; Bulut L
J Pak Med Assoc; 2016 Jul; 66(7):808-14. PubMed ID: 27427127
[TBL] [Abstract][Full Text] [Related]
5. B-type natriuretic peptide as a predictor of ischemia/reperfusion injury immediately after myocardial reperfusion in patients with ST-segment elevation acute myocardial infarction.
Arakawa K; Himeno H; Kirigaya J; Otomo F; Matsushita K; Nakahashi H; Shimizu S; Nitta M; Takamizawa T; Yano H; Endo M; Kanna M; Kimura K; Umemura S
Eur Heart J Acute Cardiovasc Care; 2016 Feb; 5(1):62-70. PubMed ID: 25609593
[TBL] [Abstract][Full Text] [Related]
6. Metabolomic Profiling in Acute ST-Segment-Elevation Myocardial Infarction Identifies Succinate as an Early Marker of Human Ischemia-Reperfusion Injury.
Kohlhauer M; Dawkins S; Costa ASH; Lee R; Young T; Pell VR; Choudhury RP; Banning AP; Kharbanda RK; ; Saeb-Parsy K; Murphy MP; Frezza C; Krieg T; Channon KM
J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29626151
[TBL] [Abstract][Full Text] [Related]
7. High Serum Secreted Frizzled-Related Protein 5 Levels Associates with Early Improvement of Cardiac Function Following ST-Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention.
Du Y; Zhao Y; Zhu Y; Hu C; Zhang J; Ji Q; Liu W; Han H; Yang L; Zhang D; Tong S; Wang Z; Guo Y; Liu X; Zhou Y
J Atheroscler Thromb; 2019 Oct; 26(10):868-878. PubMed ID: 30773518
[TBL] [Abstract][Full Text] [Related]
8. Variations in the protein level of Omi/HtrA2 in the heart of aged rats may contribute to the increased susceptibility of cardiomyocytes to ischemia/reperfusion injury and cell death : Omi/HtrA2 and aged heart injury.
Wang K; Zhang J; Liu J; Tian J; Wu Y; Wang X; Quan L; Xu H; Wang W; Liu H
Age (Dordr); 2013 Jun; 35(3):733-46. PubMed ID: 22535253
[TBL] [Abstract][Full Text] [Related]
9. Lipid Biomarkers in Acute Myocardial Infarction Before and After Percutaneous Coronary Intervention by Lipidomics Analysis.
Feng L; Yang J; Liu W; Wang Q; Wang H; Shi L; Fu L; Xu Q; Wang B; Li T
Med Sci Monit; 2018 Jun; 24():4175-4182. PubMed ID: 29913478
[TBL] [Abstract][Full Text] [Related]
10. Relation of Left Ventricular Mass and Infarct Size in Anterior Wall ST-Segment Elevation Acute Myocardial Infarction (from the EMBRACE STEMI Clinical Trial).
Daaboul Y; Korjian S; Weaver WD; Kloner RA; Giugliano RP; Carr J; Neal BJ; Chi G; Cochet M; Goodell L; Michalak N; Rusowicz-Orazem L; Alkathery T; Allaham H; Routray S; Szlosek D; Jain P; Gibson CM
Am J Cardiol; 2016 Sep; 118(5):625-31. PubMed ID: 27392509
[TBL] [Abstract][Full Text] [Related]
11. Extracellular HtrA2 Induces Apoptosis in Human Umbilical Vein Endothelial Cells.
Kaur G; Stallmann D; Schanze N; Laumann R; Heger LA; Steinfurt J; Stachon P; Peter K; Bode C; Moser M; Ahrens I; Duerschmied D; Hortmann M
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31683713
[TBL] [Abstract][Full Text] [Related]
12. Role of Omi/HtrA2 in apoptotic cell death after myocardial ischemia and reperfusion.
Liu HR; Gao E; Hu A; Tao L; Qu Y; Most P; Koch WJ; Christopher TA; Lopez BL; Alnemri ES; Zervos AS; Ma XL
Circulation; 2005 Jan; 111(1):90-6. PubMed ID: 15611365
[TBL] [Abstract][Full Text] [Related]
13. High-temperature requirement protein A2 (HtrA2): A promising biomarker to predict the ischemia-reperfusion injuries in STEMI patients.
Wang M; Ye J; Liu J; Wan J
Int J Cardiol; 2017 Dec; 249():436. PubMed ID: 29121748
[No Abstract] [Full Text] [Related]
14. Elevated serum uric acid affects myocardial reperfusion and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Mandurino-Mirizzi A; Crimi G; Raineri C; Pica S; Ruffinazzi M; Gianni U; Repetto A; Ferlini M; Marinoni B; Leonardi S; De Servi S; Oltrona Visconti L; De Ferrari GM; Ferrario M
J Cardiovasc Med (Hagerstown); 2018 May; 19(5):240-246. PubMed ID: 29470249
[TBL] [Abstract][Full Text] [Related]
15. Rationale and design of the EMBRACE STEMI study: a phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction.
Chakrabarti AK; Feeney K; Abueg C; Brown DA; Czyz E; Tendera M; Janosi A; Giugliano RP; Kloner RA; Weaver WD; Bode C; Godlewski J; Merkely B; Gibson CM
Am Heart J; 2013 Apr; 165(4):509-514.e7. PubMed ID: 23537966
[TBL] [Abstract][Full Text] [Related]
16. High-throughput targeted proteomics discovery approach and spontaneous reperfusion in ST-segment elevation myocardial infarction.
Shavadia JS; Granger CB; Alemayehu W; Westerhout CM; Povsic TJ; Brener SJ; van Diepen S; Defilippi C; Armstrong PW
Am Heart J; 2020 Feb; 220():137-144. PubMed ID: 31812755
[TBL] [Abstract][Full Text] [Related]
17. Circulating cytochrome c as potential biomarker of impaired reperfusion in ST-segment elevation acute myocardial infarction.
Marenzi G; Giorgio M; Trinei M; Moltrasio M; Ravagnani P; Cardinale D; Ciceri F; Cavallero A; Veglia F; Fiorentini C; Cipolla CM; Bartorelli AL; Pelicci P
Am J Cardiol; 2010 Nov; 106(10):1443-9. PubMed ID: 21059434
[TBL] [Abstract][Full Text] [Related]
18. Chronic Therapy With Elamipretide (MTP-131), a Novel Mitochondria-Targeting Peptide, Improves Left Ventricular and Mitochondrial Function in Dogs With Advanced Heart Failure.
Sabbah HN; Gupta RC; Kohli S; Wang M; Hachem S; Zhang K
Circ Heart Fail; 2016 Feb; 9(2):e002206. PubMed ID: 26839394
[TBL] [Abstract][Full Text] [Related]
19. Effects of Liraglutide on Reperfusion Injury in Patients With ST-Segment-Elevation Myocardial Infarction.
Chen WR; Chen YD; Tian F; Yang N; Cheng LQ; Hu SY; Wang J; Yang JJ; Wang SF; Gu XF
Circ Cardiovasc Imaging; 2016 Dec; 9(12):. PubMed ID: 27940956
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of HtrA2/Omi ameliorates heart dysfunction following ischemia/reperfusion injury in rat heart in vivo.
Bhuiyan MS; Fukunaga K
Eur J Pharmacol; 2007 Feb; 557(2-3):168-77. PubMed ID: 17182030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
